Journal article
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
Abstract
BACKGROUND: Ticagrelor demonstrated a significant reduction in major cardiac events in patients with acute coronary syndrome (ACS) compared with clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial. The objective of this study was to assess the cost-effectiveness of ticagrelor compared with clopidogrel in ACS patients from the perspective of the Canadian publicly funded health care system.
METHODS: A two-part model was …
Authors
Grima DT; Brown ST; Kamboj L; Bainey KR; Goeree R; Oh P; Ramanathan K; Goodman SG
Journal
ClinicoEconomics and Outcomes Research, Vol. 6, No. 0, pp. 49–62
Publisher
Taylor & Francis
Publication Date
January 24, 2014
DOI
10.2147/ceor.s51052
ISSN
1178-6981